Autism |
|
|
Clinical Trial: Improving Attention Skills of Children with Autism
This study is currently recruiting patients.
|
Purpose
Toddlers with autism have poor joint attention skills. Joint attention skills include pointing to objects, following another person’s gaze, and responding to invitations to join in a social interaction. Improved joint attention skills may lead to better verbal ability as the child ages. This study teaches caregivers how to help their toddlers with autism develop joint attention skills.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Autism | Behavior: Caregiver joint attention intervention | Phase I Phase II |
MedlinePlus related topics: Autism
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Placebo Control, Crossover Assignment, Efficacy Study
Official Title: A Joint Attention Intervention With Caregivers and Their Children With Autism
Expected Total Enrollment: 30
Study start: September 2001
Young children with autism show impairment in joint attention. The impairment affects their ability to sustain a shared interest in social interaction and to use specific joint attention skills, such as pointing and showing. The importance of joint attention is underscored by data suggesting these skills are important to later language skills. Targeting joint attention deficits in developmentally young children using familiar caregivers may result in better child language outcomes. This study will teach caregivers how to initiate and maintain episodes of joint engagement with their children.
Participants will be randomized to either the intervention group or to a wait list control group. Each caregiver and child in the intervention group will participate in 24 1-hour sessions, 3 times a week for 8 weeks. In these sessions, caregivers will be taught 10 different modules for teaching joint attention skills to their children. Outcome measures will include language and joint attention skills in the child and caregiver adherence to the intervention protocols. Children and caregivers will be assessed at baseline, during the course of the 8-week intervention, and 10 weeks after the end of the intervention. Participants assigned to the wait list group will begin the intervention at Week 12.
Eligibility
Ages Eligible for Study: 12 Months - 36 Months, Genders Eligible for Study: Both
Criteria
Inclusion Criteria
- Diagnosis of autism based on Autism Diagnostic Interview–Revised (ADI-R) and Autism Diagnostic Observation Schedule (ADOS) criteria
Exclusion Criteria
- Seizures
- Medical or psychiatric diagnoses other than autism that potentially contribute to developmental delay (e.g., genetic syndromes)
Location and Contact Information
California
University of California, Los Angeles, Los Angeles, California, 90095, United States; Recruiting
Connie Wong, MA 310-825-1834
Connie Kasari, PhD, Principal Investigator, University of California, Los Angelos
More Information
Record last reviewed: June 2003
Last Updated: October 13, 2004
Record first received: August 1, 2003
ClinicalTrials.gov Identifier: NCT00065910
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


